UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000023328
Receipt No. R000026867
Official scientific title of the study The introduction of laparoscopy assisted hepatectomy in living donor surgery
Date of disclosure of the study information 2016/08/01
Last modified on 2016/07/25 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study The introduction of laparoscopy assisted hepatectomy in living donor surgery
Title of the study (Brief title) Laparoscopy assisted hepatectomy in living donor surgery
Region
Japan

Condition
Condition Live donor for liver transplant
Classification by specialty
Surgery in general Hepato-biliary-pancreatic surgery
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 We will compare and evaluate the safety and the minimal invasiveness between conventional donor liver surgery and laparoscopy-assisted donor liver surgery.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes Operative data(operation time, blood loss), the details of postoperative complications, wound pain meter by Numerical Rating Scale and MPQ , QOL 1 year after donor operation by SF-36
Key secondary outcomes

In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field.

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Historical
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 1) After inserting the port (12mm) from navel, and two ports from the right lower abdomen, the mobilization of right and left lobe of liver will be performed.
2) Laparotomy will be performed via small midline incision, 10-12cm in a diameter. Donor liver surgery will be performed from small incision, as same as the conventional method.
3) After the completion of hepatectomy, liver grafts will be procured from small incisions.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required.

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit
65 years-old >
Gender Male and Female
Key inclusion criteria all live donors for transplantation
Key exclusion criteria the cases without the authorization of this study
Target sample size 50

Research contact person
Name of lead principal investigator Norio Yoshimura
Organization Kyoto Prefectural University of medicine
Division name Department of Transplant and General surgery
Address 465 Kajiicho Hirokoji Kawaramachi Kamigyo-ku, Kyoto, Japan
TEL 075-251-5532
Email orgtx@koto.kpu-m.ac.jp

Public contact
Name of contact person Taku Iida
Organization Kyoto Prefectural University of medicine
Division name Department of Transplant and General surgery
Address 465 Kajiicho Hirokoji Kawaramachi Kamigyo-ku, Kyoto, Japan
TEL 075-251-5532
Homepage URL http://www.f.kpu-m.ac.jp/k/orgtx/
Email itaku@koto.kpu-m.ac.jp

Sponsor
Institute Kyoto Prefectural University of medicine
Institute
Department

Sponsor means an organization that is responsible for plan, deployment and
report of the research including funding management. It doesn't mean
funding agency". Therefore, all clinical trial should have the one.

Funding Source
Organization self funding
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 08 Month 01 Day

Progress
Recruitment status Preinitiation
Date of protocol fixation
2016 Year 08 Month 03 Day
Anticipated trial start date
2016 Year 08 Month 22 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2016 Year 07 Month 25 Day
Last modified on
2016 Year 07 Month 25 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026867